Global Arteriotomy Closure Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Active Closure Devices and Passive Closure Devices.By Application;
Femoral Arterial Access Procedures and Radial Arterial Access Procedures.By End User;
Hospitals, Ambulatory Care Centers and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Arteriotomy Closure Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Arteriotomy Closure Devices Market was valued at USD 1,350.63 million. The size of this market is expected to increase to USD 1,990.95 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.7%.
The global arteriotomy closure devices market is a vital segment within the broader medical device industry, focusing on innovative solutions for closing puncture sites created during cardiovascular procedures. These devices play a crucial role in improving patient outcomes by reducing complications associated with traditional manual compression methods, such as prolonged recovery times and increased risk of bleeding.
Arteriotomy closure devices are designed to securely seal puncture sites in arteries post-procedure, ensuring rapid hemostasis and allowing patients to resume normal activities sooner. This capability is particularly important in minimally invasive cardiovascular procedures, where precise closure mechanisms contribute to faster recovery and shorter hospital stays.
The market for arteriotomy closure devices continues to evolve with advancements in technology, driving improvements in closure efficiency, patient comfort, and procedural safety. Innovations include the development of bioresorbable materials, enhanced sealing mechanisms, and integrated hemostatic agents, all aimed at optimizing vascular closure outcomes while minimizing procedural complications.
Geographically, North America and Europe have traditionally been leading markets due to their advanced healthcare infrastructures and high prevalence of cardiovascular diseases. However, emerging markets in Asia-Pacific and Latin America are also experiencing significant growth, fueled by increasing healthcare expenditure, rising adoption of minimally invasive procedures, and expanding access to advanced medical technologies.
Overall, the arteriotomy closure devices market is characterized by ongoing innovation, strategic partnerships among manufacturers and healthcare providers, and a growing emphasis on patient-centric outcomes. As cardiovascular procedures continue to evolve, the demand for effective, reliable, and cost-efficient closure devices is expected to drive further market expansion and technological advancements in the coming years.
Global Arteriotomy Closure Devices Market Recent Developments
- In September 2022, Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that it had earned CE mark certification for its VASCADE vascular closure and VASCADE MVP venous vascular closure systems.
- In May 2023, Teleflex Incorporated announced that it had received Health Canada approval for the MANTA Vascular Closure Device, the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.
Segment Analysis
This report extensively covers different segments of Global Arteriotomy Closure Devices Market and provides an in depth analysis segmented by Product, Application, End User and Geography.
The Global Arteriotomy Closure Devices Market is segmented into Active Closure Devices, which include devices with mechanisms like clips or sutures, and Passive Closure Devices, which rely on pressure or collagen plugs for hemostasis after cardiovascular procedures. These segments cater to different clinical needs and procedural preferences within the medical device industry.
The Global Arteriotomy Closure Devices Market, segmented by application, distinguishes between Femoral Arterial Access Procedures, commonly used in interventions like angiography and stenting, and Radial Arterial Access Procedures, favored for procedures such as cardiac catheterization and coronary interventions. These segments cater to different clinical contexts and procedural preferences within cardiovascular medicine, influencing device adoption and innovation.
The Global Arteriotomy Closure Devices Market, segmented by end user, includes hospitals, where complex cardiovascular procedures are primarily conducted, ambulatory care centers catering to outpatient interventions, and other healthcare facilities. These segments reflect varied healthcare settings that influence device adoption and usage based on procedural requirements and patient care contexts.
The Global Arteriotomy Closure Devices Market is segmented by geography, covering regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regional segmentation reflects variations in healthcare infrastructure, procedural preferences, and regulatory environments influencing device adoption and market dynamics.
Global Arteriotomy Closure Devices Segment Analysis
In this report, the Global Arteriotomy Closure Devices Market has been segmented by Product, Application, End User and Geography.
Global Arteriotomy Closure Devices Market, Segmentation by Product
The Global Arteriotomy Closure Devices Market has been segmented by Product into Active Closure Devices and Passive Closure Devices.
The global arteriotomy closure devices market is categorized into two primary product segments: active closure devices and passive closure devices. Active closure devices typically involve mechanisms such as clips, sutures, or other active components that actively secure and close the arterial puncture site post-procedure. These devices are designed to provide precise control over hemostasis, ensuring effective closure while minimizing the risk of bleeding complications. They are favored in procedures where immediate and reliable closure is critical, such as in complex cardiovascular interventions.
On the other hand, passive closure devices rely on more natural processes like pressure application or bioresorbable collagen plugs to achieve hemostasis. These devices are often simpler in design and function by promoting clot formation at the arterial puncture site without the need for active mechanical intervention. Passive closure devices are valued for their ease of use and potential cost-effectiveness, appealing to healthcare settings where procedural simplicity and reduced device complexity are priorities.
The segmentation of the arteriotomy closure devices market into active and passive categories reflects diverse clinical needs and procedural preferences among healthcare providers globally. Manufacturers continue to innovate within each segment, enhancing device efficacy, safety, and ease of use to cater to evolving patient care standards and procedural requirements in cardiovascular medicine. As the market expands, advancements in both active and passive closure technologies are expected to drive further improvements in patient outcomes and procedural efficiencies across a wide range of cardiovascular procedures.
Global Arteriotomy Closure Devices Market, Segmentation by Application
The Global Arteriotomy Closure Devices Market has been segmented by Application into Femoral Arterial Access Procedures and Radial Arterial Access Procedures.
The segmentation of the global arteriotomy closure devices market by application into femoral arterial access procedures and radial arterial access procedures reflects the diverse approaches in cardiovascular interventions. Femoral arterial access procedures typically involve accessing arteries in the groin area, commonly used for diagnostic procedures like angiography and therapeutic interventions such as stenting. Arteriotomy closure devices designed for femoral access procedures aim to provide effective hemostasis and minimize complications associated with larger arterial punctures in this anatomical region.
In contrast, radial arterial access procedures involve accessing arteries in the wrist area, preferred for procedures such as cardiac catheterization and coronary interventions. This approach offers advantages such as reduced bleeding complications, faster patient recovery times, and lower risks of vascular complications compared to femoral access. Arteriotomy closure devices tailored for radial access procedures are designed to support these benefits, focusing on securing puncture sites while facilitating patient comfort and procedural efficiency.
The segmentation by application underscores the importance of specialized arteriotomy closure devices that address the distinct clinical needs and procedural nuances associated with femoral versus radial arterial access. As healthcare providers increasingly adopt radial access due to its advantages in patient outcomes, the demand for arteriotomy closure devices tailored to radial procedures is expected to grow. Manufacturers continue to innovate within each segment to enhance device performance, safety, and usability, thereby driving advancements in cardiovascular care worldwide.
Global Arteriotomy Closure Devices Market, Segmentation by End User
The Global Arteriotomy Closure Devices Market has been segmented by End User into Hospitals, Ambulatory Care Centers and Others.
The segmentation of the global arteriotomy closure devices market by end user highlights different healthcare settings where these devices are utilized. Hospitals represent a major segment due to their role as primary centers for complex cardiovascular procedures, including angioplasty, stenting, and other interventional cardiology treatments. Arteriotomy closure devices used in hospitals are crucial for ensuring efficient hemostasis post-procedure, reducing recovery times, and minimizing complications associated with arterial punctures.
Ambulatory care centers, also known as outpatient or day surgery centers, constitute another significant end user segment in the arteriotomy closure devices market. These facilities cater to patients who undergo minimally invasive procedures such as cardiac catheterization and diagnostic angiography, often using radial arterial access. Arteriotomy closure devices in ambulatory care settings are essential for facilitating quick recovery and enabling patients to return home on the same day of the procedure, thereby enhancing patient convenience and healthcare efficiency.
The Others category in the segmentation encompasses various healthcare facilities beyond hospitals and ambulatory care centers, such as specialty clinics, academic medical centers, and independent healthcare providers. These facilities may also perform cardiovascular procedures requiring arteriotomy closure devices, albeit with varying volumes and types of procedures compared to hospitals and ambulatory care centers. The diversity within the "Others" segment underscores the broad application of arteriotomy closure devices across different healthcare settings, driven by specific procedural needs, patient demographics, and clinical practices worldwide.
Global Arteriotomy Closure Devices Market, Segmentation by Geography
In this report, the Global Arteriotomy Closure Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Arteriotomy Closure Devices Market Share (%), by Geographical Region, 2024
The global arteriotomy closure devices market is segmented by geography to account for regional variations in healthcare practices, patient demographics, and regulatory landscapes. North America typically represents a significant market share due to advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and early adoption of innovative medical technologies. The region's strong emphasis on patient outcomes and procedural efficiency drives demand for arteriotomy closure devices that facilitate quicker recovery times and minimize complications post-procedure.
Europe follows closely behind, characterized by robust healthcare systems in countries like Germany, France, and the UK, which prioritize quality care and technological advancements in cardiovascular interventions. The adoption of minimally invasive techniques, including radial artery access for cardiac catheterization, influences the demand for arteriotomy closure devices tailored to these procedures. Regulatory frameworks such as CE Marking ensure that devices meet stringent safety and efficacy standards before entering the market, contributing to reliable device performance and patient safety.
In Asia-Pacific, the arteriotomy closure devices market is expanding rapidly, driven by increasing healthcare expenditure, growing awareness of cardiovascular diseases, and rising adoption of minimally invasive procedures across countries like China, India, and Japan. Emerging economies in this region are witnessing greater investments in healthcare infrastructure and advancements in medical technology, which support the demand for arteriotomy closure devices designed to improve procedural outcomes and patient care standards. Similarly, Latin America and the Middle East & Africa regions are experiencing growth in the arteriotomy closure devices market, albeit at a slower pace, influenced by improving healthcare access and evolving treatment paradigms in cardiovascular medicine.
Overall, geographic segmentation allows stakeholders in the arteriotomy closure devices market to tailor their strategies according to regional healthcare needs, regulatory requirements, and economic dynamics, ensuring effective market penetration and sustained growth across diverse global markets.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Arteriotomy Closure Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Aging Population Growth
- Increasing Cardiovascular Procedures
- Technological Advancements
-
Rising Demand for Minimally Invasive Surgeries: The rising demand for minimally invasive surgeries (MIS) has significantly influenced the global arteriotomy closure devices market. MIS techniques involve smaller incisions compared to traditional open surgeries, leading to benefits such as reduced recovery times, shorter hospital stays, and lower risk of infection. As a result, there is a growing preference among patients and healthcare providers for procedures that utilize arteriotomy closure devices, as these devices facilitate efficient hemostasis and closure of arterial puncture sites following MIS procedures.
Advancements in medical technology have contributed to the expansion of MIS capabilities, enabling more complex procedures to be performed minimally invasively. Arteriotomy closure devices play a crucial role in supporting these advancements by providing reliable and effective closure solutions that are essential for ensuring procedural success and minimizing post-operative complications. This trend is further driven by the continuous innovation in closure device designs, which aim to enhance sealing efficacy, reduce procedure time, and improve overall patient outcomes.
The increasing adoption of arteriotomy closure devices in conjunction with MIS reflects a broader healthcare trend towards enhancing patient comfort and optimizing surgical outcomes. As healthcare systems worldwide continue to prioritize cost-effective and efficient treatment options, the demand for arteriotomy closure devices is expected to rise, presenting opportunities for market growth and innovation in the years ahead.
Restraints
- High Cost of Devices
- Lack of Reimbursement
- Complications Associated
-
Regulatory Challenges: Regulatory challenges represent a significant hurdle for manufacturers in the global arteriotomy closure devices market. These devices are subject to stringent regulations and approval processes imposed by regulatory bodies such as the FDA in the United States and the CE Marking in Europe. Compliance with these regulations is essential for ensuring the safety, efficacy, and quality of arteriotomy closure devices before they can be marketed and used in clinical settings.
Navigating regulatory pathways can be complex and time-consuming, requiring manufacturers to invest substantial resources in clinical trials, quality management systems, and documentation to demonstrate product safety and performance. Delays or uncertainties in regulatory approvals can impact product launches and market entry timelines, potentially affecting competitive positioning and revenue generation.
Regulatory requirements may vary across different regions, necessitating manufacturers to adapt their strategies and product designs to meet diverse compliance standards. These challenges underscore the importance of regulatory expertise and proactive engagement with regulatory authorities throughout the product development lifecycle. Despite these challenges, regulatory compliance remains crucial for maintaining patient safety and fostering trust among healthcare providers, ensuring that arteriotomy closure devices meet the highest standards of quality and efficacy in clinical practice.
Opportunities
- Emerging Markets Expansion
- Development of Bioresorbable Materials
- Strategic Partnerships
-
Enhanced Patient Outcomes: Enhanced patient outcomes are a central focus in the development and adoption of arteriotomy closure devices within the healthcare landscape. These devices are designed not only to achieve effective closure of arterial puncture sites but also to contribute to improved patient recovery and overall treatment success. By promoting faster hemostasis and reducing the risk of complications such as bleeding and infection, arteriotomy closure devices help enhance post-procedural comfort and facilitate earlier discharge from hospitals.
The advancement of closure device technologies plays a critical role in optimizing patient outcomes by minimizing procedural risks and supporting quicker recovery times. Innovations such as bioresorbable materials, which dissolve over time within the body, are gaining traction as they eliminate the need for device removal procedures and further enhance patient convenience. Moreover, these devices are increasingly being integrated with hemostatic agents and advanced sealing mechanisms to enhance efficacy and reliability in achieving immediate hemostasis, thereby contributing to improved clinical outcomes and patient satisfaction.
As healthcare systems worldwide prioritize value-based care and patient-centered outcomes, the demand for arteriotomy closure devices that not only meet regulatory standards but also enhance recovery experiences is expected to grow. Manufacturers and healthcare providers continue to collaborate on refining device designs and procedural techniques to further optimize outcomes, ensuring that arteriotomy closure devices play a pivotal role in advancing patient care across cardiovascular procedures.
Competitive Landscape Analysis
Key players in Global Arteriotomy Closure Devices Market include
- Abbott Laboratories
- Terumo Corporation
- Cardinal Health
- Cardiva Medical
- Merit Medical
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Arteriotomy Closure Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Aging Population Growth
- Increasing Cardiovascular Procedures
- Technological Advancements
- Rising Demand for Minimally Invasive Surgeries
- Restraints
- High Cost of Devices
- Lack of Reimbursement
- Complications Associated
- Regulatory Challenges
- Opportunities
- Emerging Markets Expansion
- Development of Bioresorbable Materials
- Strategic Partnerships
- Enhanced Patient Outcomes
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Arteriotomy Closure Devices Market, By Product, 2021 - 2031 (USD Million)
- Active Closure Devices
- Passive Closure Devices
- Global Arteriotomy Closure Devices Market, By Application, 2021 - 2031 (USD Millio)
- Femoral Arterial Access Procedures
- Radial Arterial Access Procedures
- Global Arteriotomy Closure Devices Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Ambulatory Care Centers
- Others
- Global Arteriotomy Closure Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Arteriotomy Closure Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Terumo Corporation
- Cardinal Health
- Cardiva Medical
- Merit Medica
- Company Profiles
- Analyst Views
- Future Outlook of the Market